Infectious Outcomes Following Pancreas Transplantation

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00332111

Enrollment

300

Registered

2006-06-01

Start date

2006-04-30

Completion date

2008-09-30

Last updated

2013-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Transplantation

Keywords

transplant, pancreas

Brief summary

The proposed protocol aims to characterize the infectious episodes in pancreas transplant recipients under the current medical care. Knowing these patients infectious risks, the types of infections that commonly affect them and the morbidity and mortality associated with it will provide valuable information in the evaluation of the safety and efficacy of the current practices. The information generated by this study will also serve as the basis for development of strategies targeting prophylaxis of infectious episodes.

Detailed description

The objectives of the study are: 1. To determine what is the frequency of infectious complications following pancreas transplantation 2. Characterize the clinical and microbiological aspects of the infectious complications following pancreas transplantation 3. Identify predictors for infection following pancreas transplantation 4. Determine the frequency of graft loss and associated mortality of infectious complications following pancreas transplantation

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who underwent pancreas with or without kidney transplantation at the University of Pittsburgh Medical Center from January 1st 2002 to December 31st 2005 * Patients must be above 18 years of age * Patients undergoing retransplantation may be included.

Exclusion criteria

* History of pancreas transplantation at another institution

Design outcomes

Primary

Measure	Time frame	Description
30 day outcomes after transplantation	30 days	outcomes of transplant patients post transplant

Countries

United States

Outcome results